Ideas Discussions Themes Map Live Ask AI

All beneficiaries

company

Fennec Pharmaceuticals

Information not available.

No verifiable information was found regarding Fennec Pharmaceuticals in the provided research brief.

Ideas that could help Fennec Pharmaceuticals

First-Cycle Adduct Flag for Pediatric Cisplatin Hearing ProtectionWhy it helps: Markets PEDMARK (sodium thiosulfate) for cisplatin ototoxicity; an adduct flag identifying the highest-damage children supports targeted, differentiated use of otoprotection.

Recent research, turned into concrete, commercially plausible innovation ideas — each with an interactive prototype you can try.

Explore

Ideas
Discussions
Themes
Live
Research
Map
Personas
Who benefits
Ask AI

For you

For researchers
For industry
For investors

Learn more

About
How it works
FAQ

Account

Sign in
Your space
Your stream
Your digest
Your contexts
Your data

© 2026 SeedlabsRecent research, turned into shippable ideas.